Clinical study of central serous chorioretinopathy presenting in a tertiary care centre


  • Ramamani Dalai Department of Ophthalmology, S.C.B. Medical College, Cuttack, Odisha, India
  • Rajashree Rout Department of Ophthalmology, S.C.B. Medical College, Cuttack, Odisha, India
  • Manjula Pradhan Department of Ophthalmology, S.C.B. Medical College, Cuttack, Odisha, India
  • Prasanta Kumar Nanda Department of Ophthalmology, S.C.B. Medical College, Cuttack, Odisha, India



Central serous chorioretinopathy, Fundus fluorescein angiography, Ink blot pattern, Smokestack pattern


Background: Central Serous chorioretinopathy (CSCR) is one of the common causes of visual handicap affecting young people of highly intellectual professionals at the peak of their career which can lead to irrecoverable loss of vision.

Methods: The present prospective observational population-based study was conducted in the Department of Ophthalmology, S.C.B. Medical College, Cuttack, Odisha from October 2013 to September 2015. The total number of patients attended the Outpatient Department (OPD) during the study period were 1,83,199. Amongst which 123 patients diagnosed to have CSCR were selected for the present study.

Results: Incidence of CSCR during in this study period was 0.06%. The age group most commonly affected was 31 to 40 years. Males were affected 7 times more commonly than females. Increased incidence was noticed in bank employees (21.1 %) and IT professionals (17.8%).

Conclusions: There was increased incidence of the disease in people under stressful life condition.


Wang M, Munch IC, Hasler PW, Prünte C. Larsen M Central serous chorioretinopathy. Acta Ophthalmol. 2008;86(2):126-45.

Ross A, Ross AH, Mohamed Q. Review and update of central serous chorioretinopathy. Curr Opin Ophthalmol. 2011;22(3):166-73.

Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burke JP. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. Ophthalmol. 2008;115(1):169-73.

Elias A, Gopalakrishnan M, Nair D, Bhat S, Gudapati R, Anantharaman G. A 10-Year Study of Central Serous Chorioretinopathy: Recurrence Rate and Factors affecting Recurrence. Wor J Reti Vitr. 2011;1(2):69-74.

Liew G, Quin G, Gillies M, Fraser-Bell S. Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin Exp Ophthalmol. 2013;41(2):201-14.

Gackle HC, Lang GE, FreisslerKA, Lang GK. Central serous chorioretinopathy. Clinical, fluorescein angiography and demographic aspects. Ophthalmol. 1998;95:529-33.

Qureshi T, Abdulah N, Fazili. A Clinical profile, fundus fluorescein angiographic and optical coherence tomographic finding in Central serous chorioretinopathy. J Evol Medi Dent Sci. 2013;2(34):6497-501.

Mitsui Y, Sakanashi R. Central angioplastic retinopathy. Am J Ophthalmol. 1956;41(1):105-14.

Lajmi H, Hmaied W, Ben Jalel W, Akremi A, El FekihL. Central serous chorioretinopathy: Professional repercussions among agents of the internal security forces. J Ophtalmol. 2018;41(8):739-43.

Yamada K, Hayasaka S, Setogawa T. Fluorescein-angiographic patterns in patients with central serous chorioretinopathy at the initial visit. Ophthalmologica. 1992;205:69-76.

Siddiqui SJ, Shah SIA, Pechuho MA, Abbasi SA, Shaikh FF. Pattern of Central Serous Chorioretinopathy (CSCR) on Fundus Fluorescein Angiography. Pak J Ophthalmol. 2008;24(4).

Carvalho-Recchia CA, YannuzziLA, Negrao S. Corticosteroids and central serous chorioretinopathy. Ophthalmol. 2002;109:1834-7.

JB Jonas, BA Kamppeter. Intravitreall triamcinolone acetonide and central serous chorioretinopathy. Br J Ophthalmol. 2005;89(3):386-87.

Mutlak JA, Dutton GN, Zeini M, Allan D, Wail A. Central visual function in patients with resolved Central Serous retinopathy. A long-term follow-up study. Acta Opthalmol. 1989;67:532-6.

Laatikainen L, Hoffren M. Long- term follow-up study of nonsenile detachment of the retinal pigment epithelium. Eur J Ophthalmol. 1991;1:79-84.

Castro-correia J, Coutinho MF, Rosas V, Maia J. Long-term follow-up of Central serous retinopathy in 150 patients. Doc Ophthalmol. 1992;81:379-86.

Van velthoven ME, Verbraak FD, Garcia PM, Schlingemann RO, Rosen RB, de SmetMD. Evaluation of Central serous retinopathy with enface optical coherence tomography. Br J Ophthalmol. 2005;89(11):1483-8.

Gass JD. Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol. 1967;63:1-139.

Gilbert CM, Owens SL, Smith PD, Fine SL. Long-term followup of Central serous chorioretinopathy. Br J Ophthalmol. 1984;68(11):815-20.

Loo RH, Scott IU, FLYNN Jr HW, Gass JD, Murray TG, Lewis ML, et al. Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina. 2002 Feb 1;22(1):19-24.

Yap EY, Robertson DM. The long-term outcome of Central serous chorioretinopathy. Arch Ophthalmol. 1996;114(6):689-92.

Ficker L, Vafidis G, While A, Leaver P. Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of Central serous retinopathy. Br J Ophthalmol. 1988;72(11):829-34.

Robertson DM, IIstrup D. Direct, indirect and sham laser photocoagulation in the management of central serous chorioretinopathy. Am J Ophthalmol. 1983;95(4):457-66.

D Hussain, JD Gass. Idiopathic central serous chorioretinopathy. Indian J Ophthalmol. 1998; 46(3):131-7.




How to Cite

Dalai, R., Rout, R., Pradhan, M., & Nanda, P. K. (2019). Clinical study of central serous chorioretinopathy presenting in a tertiary care centre. International Journal of Research in Medical Sciences, 7(11), 4200–4205.



Original Research Articles